Navigation Links
500 Oncology Providers Sign Up for Navigating Cancer's Patient Engagement Portal
Date:9/4/2012

SEATTLE, Sept. 4, 2012 /PRNewswire/ -- Navigating Cancer is proud to partner with over 500 oncology providers to enable them to provide a more coordinated, patient centered approach to care. Over 50% of practices are affiliated with 12 or more providers, establishing Navigating Cancer as the market leading, independent patient portal among large, influential oncology practices including Advanced Medical Specialties in Miami, Michiana Hematology Oncology in Northern Indiana, and the Center for Cancer and Blood Disorders in Fort Worth, Texas.

Designed specifically for cancer patients and staff, Navigating Cancer's cloud-based Patient Engagement Portal is EMR agnostic and integrates with any electronic medical record (EMR) system, enabling providers to more easily connect patients to their personal health information and resources to engage them in their care, a key requirement of the HITECH Act. The Patient Engagement Portal also assists providers in meeting new medical home and accountable care organization models and updated care standards from professional organizations such as the American College of Surgeon's Commission on Cancer.

"We're thrilled to be on our way to realizing our mission of connecting every cancer patient to their healthcare team, their own medical records and the right information at the right time," said Gena Cook, Navigating Cancer CEO. "We're just getting started, and are committed to building the best product to make it easier for oncology providers to engage patients in their care."

"I've been involved with numerous leading edge healthcare companies, and have yet to see a company deliver so much value to cancer patients and physicians in a shorter period of time," said John Amos, Navigating Cancer Board Member. "With over 500 oncology providers treating 150,000 new patients per year, Gena and her team have built something really special for cancer patients and the people who care for them daily."

About Navigating Cancer
Navigating Cancer's mission is to transform healthcare through patient centered care by using technology to connect cancer patients to their healthcare team, their own health records, and the right information at the right time. Navigating Cancer's Patient Engagement Portal provides oncology practices with a branded, online extension of their care model, empowering them to save time and money while providing better quality care. The company was founded in 2008 by technology and healthcare veterans and is based in Seattle, Washington.


'/>"/>
SOURCE Navigating Cancer
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. US Oncology Research Affiliated Physician to Present Findings From Innovative Clinical Trial at 2011 CTRC-AACR San Antonio Breast Cancer Symposium
2. OvaGene Oncology Collaborates With Moffitt Cancer Center to Develop and Commercialize microRNAs Associated With Chemotherapeutic Drug Response
3. Former Sanofi-aventis and US Oncology Executive Joins New Century Health as Chief Executive Officer
4. Sofie Biosciences Is Awarded a US Patent on a Family of Novel PET Probes for Use in Oncology and Immunology
5. Champions Oncology Inc. Receives Approval from U.S. Regulatory Authorities
6. Champions Oncology Reports Financial Results for the Year Ended April 30, 2012
7. New Acquisition Opens Door to Over $230m in Savings for Healthcare Providers
8. Stemline Therapeutics, Inc. Announces Two Poster Presentations of SL-401 Efficacy Data Against Lymphoid Cancers at the 53rd Annual Meeting of the American Society of Hematology (ASH)
9. QIAGEN Gains Rights to Genomic Biomarkers for Lung, Brain and Other Cancers to Expand its Pipeline of Companion Diagnostics
10. Genomic Health Presents Results From First Clinical Decision Making Study of Oncotype DX® Colon Cancer at the 2012 Gastrointestinal Cancers Symposium
11. Karyopharm Therapeutics Announces Multiple Presentations on Selective Inhibitors of Nuclear Export (SINE) in Solid and Hematologic Malignancy Models and Spontaneous Canine Cancers at the American Association of Cancer Research (AACR) Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... 27, 2016 /PRNewswire/ - BIOREM Inc. (TSX-V: BRM) ("Biorem" or ... its major shareholders, Clean Technology Fund I, LP and ... based venture capital funds which together hold ... a fully diluted, as converted basis), that they have ... entire equity holdings in Biorem to TUS Holdings Co. ...
(Date:6/27/2016)... ... 2016 , ... Parallel 6 , the leading software as a service ... Virtual Patient Encounter CONSULT module which enables both audio and video telemedicine communication ... , Using the CONSULT module, patients and physicians can schedule a face to face ...
(Date:6/27/2016)...  Liquid Biotech USA , ... Sponsored Research Agreement with The University of Pennsylvania ... cancer patients.  The funding will be used to ... clinical outcomes in cancer patients undergoing a variety ... employed to support the design of a therapeutic, ...
(Date:6/24/2016)... 24, 2016 Epic Sciences unveiled a ... susceptible to PARP inhibitors by targeting homologous recombination ... The new test has already been incorporated into ... cancer types. Over 230 clinical trials ... pathways, including PARP, ATM, ATR, DNA-PK and WEE-1. ...
Breaking Biology Technology:
(Date:5/12/2016)... , May 12, 2016 WearablesResearch.com ... just published the overview results from the Q1 wave ... the recent wave was consumers, receptivity to a program ... data with a health insurance company. "We ... to share," says Michael LaColla , CEO of ...
(Date:5/3/2016)... 3, 2016  Neurotechnology, a provider of high-precision ... Automated Biometric Identification System (ABIS) , a complete ... MegaMatcher ABIS can process multiple complex biometric transactions ... of fingerprint, face or iris biometrics. It leverages ... and MegaMatcher Accelerator , which have been ...
(Date:4/28/2016)... -- First quarter 2016:   , Revenues ... first quarter of 2015 The gross margin was 49% ... and the operating margin was 40% (-13) Earnings per ... from operations was SEK 249.9 M (21.2) , Outlook ... 7,000-8,500 M. The operating margin for 2016 is estimated ...
Breaking Biology News(10 mins):